1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Isoform

CXCR

 

CXCR Related Products (20):

Cat. No. Product Name Effect Purity
  • HY-18981
    Decursin
    99.94%
    Decursin ((+)-Decursin) is a potent anti-tumor agent.
  • HY-107536
    ML 145
    98.01%
    ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM.
  • HY-19519
    Ladarixin
    Antagonist 98.05%
    Ladarixin (DF 2156A free base) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist.
  • HY-P0172A
    ATI-2341 TFA
    Agonist 99.08%
    ATI-2341 is a potent and functionally selective allosteric agonist of C-X-C chemokine receptor type 4 (CXCR4), which functions as a biased ligand, favoring Gαi activation over Gα13.
  • HY-16509
    UNBS5162
    Antagonist 99.92%
    UNBS5162 is a pan-antagonist of CXCL chemokine expression, with anti-tumor activity.
  • HY-P99190
    Eldelumab
    Inhibitor
    Eldelumab (BMS-936557) is a humanised anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type).
  • HY-151559
    Zn-DPA-maytansinoid conjugate 1
    Modulator
    Zn-DPA-maytansinoid conjugate 1 is a small molecule-based maytansinoid conjugate targeting immune checkpoint.
  • HY-145640
    Vimnerixin
    Antagonist 99.39%
    Vimnerixin (AZD4721) is the potent and orally active antagonist of acidic CXC chemokine receptor 2 (CXCR2).
  • HY-120878A
    (R,R)-CXCR2-IN-2
    Antagonist 99.37%
    (R,R)-CXCR2-IN-2, diastereoisomer of CXCR2-IN-2 (compound 68), is a brain penetrant CXCR2 antagonist with a pIC50 of 9 and 6.8 in the Tango assay and d in the HWB Gro-α induced CD11b expression assay, respectively.
  • HY-142617
    ACT-1004-1239
    Antagonist
    ACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC50 value of 3.2 nM.
  • HY-101033
    GPR35 agonist 1
    GPR35 agonist 1 (compound 50) is a potent and specific G protein-coupled receptor-35 (GPR35)/CXCR8 agonist with an EC50 of 5.8 nM, displays good druggability.
  • HY-144347
    HF51116
    Antagonist
    HF51116 is a potent antagonist of CXCR4.
  • HY-16981
    SB-332235
    Antagonist
    SB-332235 is a potent, orally active nonpeptide CXCR2 antagonist, with an IC50 of 7.7 nM.
  • HY-N2573A
    Corydalmine hydrochloride
    Inhibitor
    Corydalmine hydrochloride inhibits spore germination of some plant pathogenic as well as saprophytic fungi.
  • HY-125567
    Antileukinate
    Inhibitor
    Antileukinate, a hexapeptide, is a potent inhibitor of CXC-chemokine receptor (CXCR).
  • HY-139874
    CXCR2 antagonist 3
    Antagonist
    CXCR2 antagonist 3 (compound 11h) is a potent antagonist of CXC chemokine receptor 2 (CXCR2).
  • HY-10046S
    Plerixafor-d4
    Antagonist
  • HY-139873
    CXCR2 antagonist 2
    Antagonist 99.12%
    CXCR2 antagonist 2 is a potent CXCR2 antagonist for cancer immunotherapy with an IC50 value of 95 nM.
  • HY-15319A
    (±)-AMG 487
    Inhibitor
    (±)-AMG 487 is a racemate of AMG 487.
  • HY-132936
    CXCR4 antagonist 2
    Antagonist
    CXCR4 antagonist 2 is a CXCR4 antagonist with an IC50 value of 47 nM.